Urelumab

Urelumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Urelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma. Urelumab is a fully human antibody that targets CD137. The antibody product was developed using Medarex's UltiMAb(R) technology and was the first UltiMAb- derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with Medarex.

Trade Name Urelumab
Generic Urelumab
Urelumab Other Names Urelumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Urelumab
Urelumab

Innovators Monograph

You find simplified version here Urelumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share